Dunn M A, Maragoudakis M E, Hait P K
Biochim Biophys Acta. 1978 Jan 18;538(2):328-33. doi: 10.1016/0304-4165(78)90360-4.
The activity of procollagen prolyl hydroxylase was measured in fibrotic liver obtained from mice with hepatosplenic schistosomiasis, an animal model of the most prevalent form of human liver fibrosis. Measurable activity of prolyl hydroxylase in fibrotic liver supernatants was 47-fold higher than that of normal liver. The effect of prolyl hydroxylase inhibition on collagen synthesis in fibrotic liver slices was studied, using 8,9-dihydroxy-7-methyl benzo[b]quinolizinium bromide (GPA 1734). This compound was shown in other systems to inhibit prolyl and lysyl hydroxylations by iron chelation at concentrations which did not affect total protein synthesis. The formation of nondialyzable labelled hydroxyproline was inhibited by GPA 1734, 40, 70 and 95% at 30, 50 and 100 micrometer, respectively. Incorporation of proline into total liver protein was unaffected at 30 and 50 micrometer, but was inhibited 20% at 100 micrometer GPA 1734. Underhydroxylated collagen synthesized by liver slices with GPA 1734 was extracted with neutral salt solution and was subsequently hydroxylated with partially-purified prolyl hydroxylase to the same extent as control material synthesized in the absence of GPA 1734.
在肝脾血吸虫病小鼠的纤维化肝脏中检测了前胶原脯氨酰羟化酶的活性,肝脾血吸虫病是人类最常见的肝纤维化形式的动物模型。纤维化肝脏上清液中脯氨酰羟化酶的可测量活性比正常肝脏高47倍。使用8,9-二羟基-7-甲基苯并[b]喹嗪鎓溴化物(GPA 1734)研究了脯氨酰羟化酶抑制对纤维化肝切片中胶原合成的影响。在其他系统中已表明,该化合物在不影响总蛋白合成的浓度下通过铁螯合作用抑制脯氨酰和赖氨酰羟化。GPA 1734分别在30、50和100微摩尔浓度下对不可透析标记羟脯氨酸的形成抑制率为40%、70%和95%。在30和50微摩尔浓度下,脯氨酸掺入肝脏总蛋白不受影响,但在100微摩尔GPA 1734浓度下受到20%的抑制。用中性盐溶液提取经GPA 1734处理的肝切片合成的羟化不足的胶原,随后用部分纯化的脯氨酰羟化酶将其羟化至与在无GPA 1734条件下合成的对照材料相同的程度。